Orgaia’s Prof Giovanni Scapagnini gave a keynote address on INNOVATION at the ‘Global trends, Regulation and Innovation in Food Supplements’ Summit in Italy.
His talk covered the topic:
The global food supplement market is estimated to reach 250 billion$ in 2018 with a CAGR of 7% over the forecast period. The key drivers of growth will be related to increasing consumer awareness and education on the role of food supplements as part of a balanced, healthy lifestyle, allowing consumers to make better-informed choices. Overwhelming evidence now supports the effects of food supplements – concentrates of important nutrients such as vitamins, minerals, amino and fatty acids and other substances with a nutritional or physiological effect – in various life stages.
Orgaia’s Prof. Scapagnini joined other world class scientists at the MILAN WORLD EXPO. Prof Scapagnini gave a talk on Nutraceuticals and brain protection as part of his role of Member of the Scientific Committee of the conference.
Nutraceuticals today are no longer just “food supplements”. They are among the main fighters against cardio-metabolic risk factors. Products such as extracts of red rice, phytosterols and omega-3 fish are ideal for a wide segment of the population that needs a preventive intervention for moderate alterations of cholesterol / triglycerides. For hypertensive people they offer amazing results using beet juice, bitter chocolate and its extracts: flavanols. But nutraceuticals have now achieved goals far more extensive. Today the prevention and treatment of early forms of macular degeneration, the eye disease of blindness in the elderly, is dramatically improved with the use of nutraceuticals. Such is the case of joint diseases and food integrators in sports, which avoids the risk of potential doping. Nutraceuticals also differentiate gender needs and requirements, with treatments directed to pregnancy, breastfeeding and menopause. Nutraceuticals also target areas where pharma has failed. Among these some neurological diseases, in particular Alzheimer’s disease, faced with new perspectives, different from ineffective therapies of anti beta-amyloids. They also offer important innovations in the treatment of obesity.